Explore how the biotechnology industry can effectively engage with the U.S. Government to advance the development and deployment of medical countermeasures essential to national security. This multi-panel session will highlight strategies for partnering across key agencies to strengthen domestic and international health security, support military readiness, and drive innovation for an all-hazards preparedness and response strategy. Experts will discuss approaches to scaling medical countermeasures, leveraging emerging platforms and technologies, expanding manufacturing capacity, and enhancing public-private collaboration to meet evolving biological threats. Attendees will gain actionable insights into aligning their capabilities with U.S. government priorities and contributing to a resilient national biodefense infrastructure.